From Discovery to Patient Care: Vitamin D analog shuts down pancreatic cancer's shield in clinical trial
May 27, 2026
May 27, 2026
BOSTON, Massachusetts, May 27 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release:
* * *
From Discovery to Patient Care: Vitamin D analog shuts down pancreatic cancer's shield in clinical trial
*
Small clinical trial led by Dana-Farber Cancer Institute builds on Salk Institute's foundational research on vitamin D receptor and tumor microenvironment
A small clinical trial led by D . . .
* * *
From Discovery to Patient Care: Vitamin D analog shuts down pancreatic cancer's shield in clinical trial
*
Small clinical trial led by Dana-Farber Cancer Institute builds on Salk Institute's foundational research on vitamin D receptor and tumor microenvironment
A small clinical trial led by D . . .
